The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Alexion Pharmaceuticals; Aravive; AstraZeneca; Clovis Oncology; Janssen; Johnson & Johnson; Merck; Mersana; Myriad Pharmaceuticals; OncoQuest; Roche/Genentech; Tesaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Aravive; AstraZeneca; Clovis Oncology; Janssen; Johnson & Johnson; Merck; Mersana; Myriad Pharmaceuticals; OncoQuest; Roche/Genentech; Tesaro
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Eisai; Endocyte; Exelixis; Incyte; Merck; PharmaMar; Prima BioMed; Roche/Genentech; Seagen; TapImmune Inc.; Tesaro
 
Honoraria - Amgen; AstraZeneca; MSD; Novartis; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca; Cerulean Pharma; MSD; Novartis; Pfizer; PharmaMar; Roche; Tesaro; Vertex
Research Funding - AstraZeneca; Roche
 
Travel, Accommodations, Expenses - Roche
AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer.
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Maria Pilar Barretina-Ginesta
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche; Tesaro
Speakers' Bureau - AstraZeneca; Roche; Tesaro
Travel, Accommodations, Expenses - PharmaMar; Roche; Tesaro
 
Philip James Beale
No Relationships to Disclose
 
Kenichi Harano
Honoraria - AstraZeneca; Chugai Pharma; Eisai; MSD; Taiho Pharmaceutical
Consulting or Advisory Role - Takeda
 
Emma Hudson
Honoraria - Tesaro
 
Frederik Marmé
Honoraria - AstraZeneca; Celgene; Clovis Oncology; Eisai; MSD; Pfizer; Roche; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca; CureVac; Eisai; MSD; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Pfizer; PharmaMar; Roche
 
Christian Marth
No Relationships to Disclose
 
Manuela Radaglio
No Relationships to Disclose
 
Angeles Alvarez Secord
No Relationships to Disclose
 
Roldano Fossati
No Relationships to Disclose
 
Anna Roberto
No Relationships to Disclose
 
Eliana Rulli
No Relationships to Disclose
 
Francesca Tettamanzi
Travel, Accommodations, Expenses - Roche
 
Elena Biagioli
No Relationships to Disclose